Abstract | BACKGROUND AND PURPOSE: METHODS: RESULTS:
Prothrombin 19911 A>G did not increase the risk of CSVT in carriers of factor V Leiden (adjusted odds ratio 1.6, 95%CI 0.6–4.7), prothrombin 20210 GA (odds ratio 1.1, 95%CI 0.6–2.2), nor in patients without known thrombophilia (odds ratio 1.3, 95%CI 0.5–3.1). CONCLUSIONS:
|
Authors | I Martinelli, P Bucciarelli, V De Stefano, S M Passamonti, M Menegatti, D Tormene, A Tosetto, P M Mannucci |
Journal | European journal of neurology
(Eur J Neurol)
Vol. 17
Issue 12
Pg. 1482-5
(Dec 2010)
ISSN: 1468-1331 [Electronic] England |
PMID | 20482605
(Publication Type: Journal Article)
|
Copyright | © 2010 The Author(s). European Journal of Neurology © 2010 EFNS. |
Chemical References |
- factor V Leiden
- Factor V
- Prothrombin
|
Topics |
- Adolescent
- Adult
- Aged
- Case-Control Studies
- Child
- Child, Preschool
- Factor V
(genetics)
- Female
- Genetic Predisposition to Disease
- Humans
- Infant
- Male
- Middle Aged
- Polymorphism, Genetic
- Prothrombin
(genetics)
- Sinus Thrombosis, Intracranial
(genetics)
- Thrombophilia
(genetics)
|